![Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD](https://cdn.newsserve.net/ONPglobe256.png)
Dermavant Announces Publication of ADORING 1 & ADORING 2 Pivotal Phase 3 Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children 2 Years of Age and Older with Atopic Dermatitis in JAAD
LONG BEACH, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Dermavant Publishes ADORING 1 & 2 Pivotal Trials of VTAMA® (tapinarof) cream, 1% for Adults and Children with Atopic Dermatitis in JAAD
Full Article